NM_000426.4:c.7604G>A
Variant summary
Our verdict is Uncertain significance. The variant received 5 ACMG points: 6P and 1B. PM2PP3_StrongBP6
The NM_000426.4(LAMA2):c.7604G>A(p.Gly2535Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000161 in 1,613,600 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000426.4 missense
Scores
Clinical Significance
Conservation
Publications
- congenital merosin-deficient muscular dystrophy 1AInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Myriad Women’s Health, G2P
- LAMA2-related muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- muscular dystrophy, limb-girdle, autosomal recessive 23Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 5 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000426.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LAMA2 | NM_000426.4 | MANE Select | c.7604G>A | p.Gly2535Asp | missense | Exon 55 of 65 | NP_000417.3 | ||
| LAMA2 | NM_001079823.2 | c.7592G>A | p.Gly2531Asp | missense | Exon 54 of 64 | NP_001073291.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LAMA2 | ENST00000421865.3 | TSL:5 MANE Select | c.7604G>A | p.Gly2535Asp | missense | Exon 55 of 65 | ENSP00000400365.2 | ||
| LAMA2 | ENST00000618192.5 | TSL:5 | c.7868G>A | p.Gly2623Asp | missense | Exon 56 of 66 | ENSP00000480802.2 | ||
| LAMA2 | ENST00000617695.5 | TSL:5 | c.7592G>A | p.Gly2531Asp | missense | Exon 54 of 64 | ENSP00000481744.2 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 151976Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000358 AC: 9AN: 251148 AF XY: 0.0000295 show subpopulations
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461624Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727120 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000395 AC: 6AN: 151976Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74208 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.7604G>A (p.G2535D) alteration is located in exon 55 (coding exon 55) of the LAMA2 gene. This alteration results from a G to A substitution at nucleotide position 7604, causing the glycine (G) at amino acid position 2535 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
not provided Uncertain:1
LAMA2-related muscular dystrophy Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at